ADY Stock Overview
Provides healthcare services in the United States. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 4/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Amedisys, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$84.00 |
52 Week High | US$89.50 |
52 Week Low | US$81.00 |
Beta | 0.78 |
11 Month Change | -5.08% |
3 Month Change | -2.33% |
1 Year Change | -0.59% |
33 Year Change | -40.00% |
5 Year Change | -43.24% |
Change since IPO | 389.30% |
Recent News & Updates
Recent updates
Shareholder Returns
ADY | DE Healthcare | DE Market | |
---|---|---|---|
7D | -0.6% | 0.3% | -1.3% |
1Y | -0.6% | 15.7% | 7.4% |
Return vs Industry: ADY underperformed the German Healthcare industry which returned 14.5% over the past year.
Return vs Market: ADY underperformed the German Market which returned 7.1% over the past year.
Price Volatility
ADY volatility | |
---|---|
ADY Average Weekly Movement | 2.0% |
Healthcare Industry Average Movement | 4.1% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.8% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: ADY has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: ADY's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1982 | 19,000 | Richard Ashworth | www.amedisys.com |
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.
Amedisys, Inc. Fundamentals Summary
ADY fundamental statistics | |
---|---|
Market cap | €2.81b |
Earnings (TTM) | €79.12m |
Revenue (TTM) | €2.21b |
35.6x
P/E Ratio1.3x
P/S RatioIs ADY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ADY income statement (TTM) | |
---|---|
Revenue | US$2.32b |
Cost of Revenue | US$1.31b |
Gross Profit | US$1.01b |
Other Expenses | US$930.68m |
Earnings | US$82.93m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 2.53 |
Gross Margin | 43.67% |
Net Profit Margin | 3.57% |
Debt/Equity Ratio | 29.4% |
How did ADY perform over the long term?
See historical performance and comparison